Biotech solutions at a critical time for Canada

Canada has a strong biotech foundation upon which to build, but there remain some headwinds to be addressed.

As Canada begins to emerge from under the pandemic and return to some sort of normal, there will always be the risk of new priorities and challenges drawing attention from finishing the important investments and work already underway, says Andrew Casey, president and CEO of BIOTECanada.Photograph courtesy of Pixabay

Opinion

BY Andrew Casey

September 12, 2022

The central value of the biotechnology sector has always been the solutions it brings to the challenge of a global population moving quickly to 10 billion people and the imperative of finding ways to fundamentally alter how we grow, manufacture, cure, and fuel our economies and societies. Not surpri...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy